Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rocket Pharmaceuticals (RCKT) Preferred Shares Issued (2017)

Historic Preferred Shares Issued for Rocket Pharmaceuticals (RCKT) over the last 1 years, with Q3 2017 value amounting to -$39000.0.

  • Rocket Pharmaceuticals' Preferred Shares Issued changed N/A to -$39000.0 in Q3 2017 from the same period last year, while for Jun 2018 it was -$39000.0, marking a year-over-year change of. This contributed to the annual value of $25.4 million for FY2017, which is 8458666.67% up from last year.
  • Latest data reveals that Rocket Pharmaceuticals reported Preferred Shares Issued of -$39000.0 as of Q3 2017.
  • Rocket Pharmaceuticals' Preferred Shares Issued's 5-year high stood at $21.5 million during Q1 2017, with a 5-year trough of -$39000.0 in Q3 2017.